M. A. Davies

746 total citations
13 papers, 50 citations indexed

About

M. A. Davies is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M. A. Davies has authored 13 papers receiving a total of 50 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in M. A. Davies's work include Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Brain Metastases and Treatment (3 papers). M. A. Davies is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Brain Metastases and Treatment (3 papers). M. A. Davies collaborates with scholars based in United States and Poland. M. A. Davies's co-authors include Patrick Hwu, Janet Dancey, Agop Y. Bedikian, Wuh‐Liang Hwu, Nicholas E. Papadopoulos, James R. Wright, Michael B. Atkins, Scott E. Woodman, Alexander J. Lazar and Gladys Alvarado and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M. A. Davies

12 papers receiving 49 citations

Peers

M. A. Davies

ONCOL

PRM

IMMUN

CTM

N. Basset Seguin France

Jennifer G. Reeder United States

Amy Lew Tsuhako United States

Joseph M. Gurski United States

Emily A. Costa United States

Cathy Lanagan Australia

Priya S. Hibshman United States

Li-Ping Hsiao Taiwan

Merna Sitto United States

N. Basset Seguin France

M. A. Davies

29 ×0.7

31 ×0.8

ONCOL

5 ×0.6

PRM

6 ×1.2

IMMUN

6 ×1.5

CTM

Citations per year, relative to M. A. Davies M. A. Davies (= 1×) peers N. Basset Seguin

Countries citing papers authored by M. A. Davies

Since Specialization

Citations

This map shows the geographic impact of M. A. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Davies more than expected).

Fields of papers citing papers by M. A. Davies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Davies. The network helps show where M. A. Davies may publish in the future.

Co-authorship network of co-authors of M. A. Davies

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Davies. A scholar is included among the top collaborators of M. A. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Davies. M. A. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Mitra, Devarati, Priyadharsini Nagarajan, Andrew J. Bishop, et al.. (2021). 30-Year Experience Managing Anorectal Melanoma With Sphincter-Sparing Local Excision and Hypofractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 111(3). e60–e60. 1 indexed citations

Shephard, Michael, Lauren E. Haydu, Rodabe N. Amaria, et al.. (2019). Outcomes of patients with melanoma brain metastases (MBM) treated with standard of care therapy after being excluded from MBM-specific clinical trials. Annals of Oncology. 30. v555–v555. 1 indexed citations

Grob, Jean‐Jacques, Victoria Atkinson, Caroline Robert, et al.. (2019). Adverse event (AE) kinetics in patients (pts) treated with dabrafenib + trametinib (D + T) in the metastatic and adjuvant setting. Annals of Oncology. 30. v543–v544. 3 indexed citations

Glitza, Isabella C., Michelle Rohlfs, Jessie Richard, et al.. (2015). 517 Long-term efficacy of intrathecal interleukin-2 (IT IL2) in metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD). European Journal of Cancer. 51. S109–S109. 1 indexed citations

Kim, Sangbae, Bo Hwa Sohn, Yun‐Yong Park, et al.. (2013). Abstract 5222: Identification of cell signaling pathway associated miRNAs in cancer cells using a systems biological approach.. Cancer Research. 73(8_Supplement). 5222–5222.

Lazar, Alexander J., M. A. Davies, Jade Homsi, et al.. (2011). BRAF, NRAS, and KIT mutational analysis of spindle cell melanoma.. Journal of Clinical Oncology. 29(15_suppl). 8589–8589. 1 indexed citations

Jakob, John, Alexander J. Lazar, Gladys Alvarado, et al.. (2011). Clinical characteristics and outcomes associated with BRAF and NRAS mutations in metastatic melanoma.. Journal of Clinical Oncology. 29(15_suppl). 8500–8500. 14 indexed citations

Patel, Sunil, A. Y. Bedikian, Nicholas E. Papadopoulos, et al.. (2011). Ipilimumab plus temozolomide in metastatic melanoma.. Journal of Clinical Oncology. 29(15_suppl). 8579–8579. 7 indexed citations

Papadopoulos, Nicholas E., Wen-Jen Hwu, Liberty Posada, et al.. (2011). Phase I trial of temozolomide, thalidimide, and lomustine in patients with metastatic melanoma in the brain.. Journal of Clinical Oncology. 29(15_suppl). 8571–8571. 1 indexed citations

10.

Joseph, Robiya, Patrick Hwu, M. A. Davies, Michael B. Atkins, & Ryan J. Sullivan. (2011). Clinical benefit of ipilimumab in patients with metastatic melanoma who progress on high-dose IL-2.. Journal of Clinical Oncology. 29(15_suppl). 8537–8537. 3 indexed citations

11.

Joseph, Robiya, Ryan J. Sullivan, D J Panka, et al.. (2010). Effect of mutational status on response, PFS, or OS after treatment with IL-2 for metastatic melanoma.. Journal of Clinical Oncology. 28(15_suppl). 8597–8597. 2 indexed citations

12.

Homsi, Jade, Agop Y. Bedikian, Nicholas E. Papadopoulos, et al.. (2009). Randomized trial of two schedules of palonosetron for the prevention of nausea and vomiting in patients with metastatic melanoma receiving interleukin-2–based concurrent biochemotherapy. Journal of Clinical Oncology. 27(15_suppl). e20008–e20008. 1 indexed citations

13.

Davies, M. A., Nicholas E. Papadopoulos, Agop Y. Bedikian, et al.. (2009). Phase I/II study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma. Journal of Clinical Oncology. 27(15_suppl). 9026–9026. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact